News - Cortado Ventures

Recent Cortado news, media & events

Blog Posts | Newsletters | Podcasts

Recent news & events

Empowering Women in Legacy Sectors: Celebrating Innovators in Manufacturing and Supply Chain

Mar 25, 2024 | Blog

Read the full story here Authored by Susan Morning, Cortado Ventures General Partner In an industry where women are still significantly underrepresented with women representing just 8.6% of all venture capitalists and 8% of firm partners across the country, and...

Why We Invested: Cadenza Bio

Mar 11, 2024 | Blog

Read Why We Invested in Cadenza Bio on our Medium page. Authored by Mansi Patel, Cortado Ventures Analyst Novel therapeutic drugs for the treatment of neurodegenerative diseases Cortado Ventures is thrilled to have recently invested in Cadenza Bio, an...

Forbes: Cortado Ventures Recognized for Diversity Advocacy

Mar 5, 2024 | Media

At Cortado Ventures, we are proud to be recognized by Forbes for our commitment to supporting diversity in entrepreneurship. In a recent feature by Forbes contributor Soulaima Gourani, our efforts to empower minority entrepreneurs were highlighted, showcasing our...

Nuview: Nuview Acquires Astraea

Feb 22, 2024 | Media

As part of the relentless pursuit to redefine the boundaries of Earth observation, Nuview announced its acquisition of Astraea, a leading spatial intelligence platform. This strategic move marks a significant milestone in their journey to revolutionize the Earth...

Ardley: Launches Underwriting Engine

Feb 22, 2024 | Media

Nathan Den Herder, CEO and Founder of Ardley sits down for an exclusive interview to discuss the launch of their cutting-edge autopilot underwriting engine. Featured in top publications, including Housingwire, Mortgage Bankers Association, National Mortgage News and...

Cody Merrill: A Cortado Conversation with CorriXR Therapeutics CEO Deborah Moorad

Feb 22, 2024 | Blog

A Cortado Conversation with CorriXR Therapeutics CEO Deborah Moorad Read the full story here Cortado is thrilled to invest in CorriXR Therapeutics, an early-stage biotech company commercializing a platform gene editing technology with a first-use case in oncology. The...